Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes

The Cleveland Clinic · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
diabetes-mellitusobesitytype-2
diabetes mellitus, type 2, obesity, post-bariatric surgery, hemoglobin a1c protein, human, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 833618
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.